Fundalysisby DARKHORSESTOCKS

Stock · INE634S01028

Mankind Pharma Limited

Held by 172 schemes worth ₹9,938 Cr in Sept 2026.

Schemes holding Mankind Pharma Limited(Apr 2023 – Sept 2026)

Schemes holding Mankind Pharma Limited in Sept 2026. Tick up to 2 to plot them.
Plot172 schemes · ₹ Cr
SBI Large Cap Fund
1,020
Nippon India Growth Mid Cap Fund
976
HDFC Large Cap Fund
686
Nippon India Large Cap Fund
534
Aditya Birla Sun Life Flexi Cap Fund
519
Nippon India Pharma Fund
402
Aditya Birla Sun Life Large Cap Fund
378
HSBC Midcap Fund
374
Mirae Asset Midcap Fund
358
ICICI Prudential Healthcare Fund
346
SBI Contra Fund
333
Axis ELSS Tax Saver Fund
230
Nippon India ELSS Tax Saver Fund
224
Tata Mid Cap Fund
200
Kotak Small Cap Fund
199
Sundaram Mid Cap Fund
199
Nippon India Flexi Cap Fund
172
Axis Midcap Fund
162
SBI Healthcare Opportunities Fund
100
Aditya Birla Sun Life ELSS Tax Saver Fund
98.8
Aditya Birla Sun Life Large Mid Cap Fund
86.1
Bank Of India Flexi Cap Fund
82.6
Sundaram Aggressive Hybrid Fund
78.4
Mirae Asset Healthcare Fund
78.4
ICICI Prudential Balanced Advantage Fund
78.1
Canara Robeco Flexicap Fund
71.3
Mirae Asset Small Cap Fund
67
Tata Large Mid Cap Fund
65.1
Mirae Asset Flexi Cap Fund
64.4
Nippon India Multi Asset Allocation Fund
64
SBI ESG Exclusionary Strategy Fund
62.6
Tata Large Cap Fund
62.6
HSBC Large Mid Cap Fund
60.9
Aditya Birla Sun Life Multi Asset Allocation Fund
60.8
Canara Robeco Large Cap Fund
58.6
Kotak Pioneer Fund
54.7
HSBC Focused Fund
52.6
Kotak Business Cycle Fund
50.4
Nippon India Nifty Pharma ETF
50
Nippon India Balanced Advantage Fund
47.6
WhiteOak Capital Mid Cap Fund
43.4
Bank of India Aggressive Hybrid Fund
40.1
Aditya Birla Sun Life Pharma Healthcare Fund
39
DSP Dynamic Asset Allocation Fund
38.5
HSBC Multi Asset Allocation Fund
38.4
HSBC Large Cap Fund
37.6
HDFC Business Cycle Fund
36.2
Aditya Birla Sun Life Consumption Fund
35.9
Invesco India Flexi Cap Fund
34.3
Baroda BNP Paribas Mid Cap Fund
29.8
  • SBI Large Cap Fund
  • Nippon India Growth Mid Cap…
Market value of Mankind Pharma Limited in each ticked scheme, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.
MonthSBI Large Cap FundNippon India Growth Mid Cap Fund
Sept 2025₹992 Cr₹0 Cr
Oct 2025₹971 Cr₹0 Cr
Nov 2025₹917 Cr₹288 Cr
Dec 2025₹895 Cr₹281 Cr
Jan 2026₹865 Cr₹314 Cr
Feb 2026₹915 Cr₹333 Cr
Mar 2026₹817 Cr₹297 Cr
Apr 2026₹915 Cr₹517 Cr
May 2026₹968 Cr₹808 Cr
Jun 2026₹1,037 Cr₹866 Cr
Jul 2026₹1,006 Cr₹857 Cr
Aug 2026₹985 Cr₹943 Cr
Sept 2026₹1,020 Cr₹976 Cr
Fig. 1.Market value of Mankind Pharma Limited in each ticked scheme, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.

Allocation(Sept 2026)

Fund houses

24 fund houses% of total
Nippon
1225.52
SBI
815.48
Aditya Birla
1412.59
HDFC
87.36
HSBC
65.96
Mirae
125.93
ICICI
104.71
Axis
114.58
Kotak
123.57
Tata
73.55
Other fund houses
7210.76

Scheme types

Schemes

Fig. 2.What mutual funds hold of this company, by fund house, by scheme type and by scheme. Hover a slice or a row; click a slice to open it.

Schemes buying and selling Mankind Pharma Limited(Oct 2025 – Sept 2026)

Schemes buying and selling Mankind Pharma Limited. Change in market value since the previous month, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.
Fig. 3.Change in market value since the previous month, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.